Nuvectis Pharma, Inc.

Historical 13F Holders

Symbol
NVCT
CUSIP
67080T108
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 67080T108 since 12/18/2024, largest first.

Filer % of Class Filed
Soleus Private Equity Fund III, L.P. 13G
5.1% 8/6/2026
Event 8/4/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 96 12.9 M $272M
2026 Q2 84 10.2 M $189M
2026 Q1 63 4.52 M $34.9M
2025 Q4 50 4.24 M $32.0M
2025 Q3 54 3.69 M $22.2M
2025 Q2 49 3.24 M $24.2M
2025 Q1 35 2.05 M $20.0M
2024 Q4 32 1.32 M $7.15M
2024 Q3 32 1.05 M $6.60M
2024 Q2 42 1.21 M $7.63M
2024 Q1 41 1.56 M $12.8M
2023 Q4 37 1.51 M $12.6M
2023 Q3 34 1.28 M $16.5M
2023 Q2 38 1.25 M $20.0M
2023 Q1 14 484 k $6.34M
2022 Q4 12 984 k $7.38M
2022 Q3 13 1.42 M $10.0M
2022 Q2 12 643 k $7.20M
2022 Q1 9 628 k $4.65M